Transitional Cell Carcinoma Express Vitamin D Receptors

References

• Andersen C B, Blaehr H, Ladefoged S, Larsen S. Expression of the intercellular adhesion molecule-1 (ICAM-1) in human renal allografts and cultured human tubular cells. Nephrol Dial Transplant 1992; 7: 147–154
   PubMed Web of Science ®Google Scholar
• Bergquist A, Ljungquist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 1985; 130: 371–378
   Google Scholar
• Bikle D D. Clinical counterpoint: vitamin D: New actions, new analogs, new therapeutic potential. Endocrine Rev 1992; 13: 765–784
   PubMed Web of Science ®Google Scholar
• Binderup L. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: Effects on cell growth regulation in vitro and calcium metabolism in vivo. Pharmacol Toxicol 1993; 72: 240–244
   PubMedGoogle Scholar
• Binderup L, Latini S, Binderup E, Bretting C, Calverley M, Hansen K. 20-epi-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991; 42: 1569–1575
   PubMed Web of Science ®Google Scholar
• Bouillon R, Allewaert K, Xiang D Z, Tan B K, van Baelen H. Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activity. J Bone Miner Res 1991; 6: 1051–1057
   PubMed Web of Science ®Google Scholar
• Bower M, Colston K W, Stein R C. Topical calcipotriol treatment in advanced breast cancer. Lancet 1991; 337: 701–702
   PubMed Web of Science ®Google Scholar
• Bubenik J, Kieler J, Tromholt V, Hermann G, Jandlova T. Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma. Immunol Lett 1988; 18: 115–118
   PubMed Web of Science ®Google Scholar
• Colston K W, Chander S K, Mackay A G, Coombest R C. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 1992; 44: 693–702
   PubMed Web of Science ®Google Scholar
• Dow J A, di Sant'Agnese P A, Cockett A TK. Expression of blood group precursor T antigen as a prognostic marker for human bladder cancer treated by bacillus calmette-guerin and interleukin-2. J Urol 1989; 142: 978–982
   PubMed Web of Science ®Google Scholar
• Fukui K, Hamada K, Kihana T, et al. Inhibition of the growth of human endometrial cell line in vitro by various vitamin D3 analogue (Abstract). Proc Am Assoc Cancer Res 1992; 33: 284–284
   Google Scholar
• Hermann G G. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma. APMIS 1993; 101(Suppl 35)1–26
   PubMedGoogle Scholar
• Hermann G G, Geertsen P F, von der Maase H, et al. Recombinant interleukin-2 and LAK cell treatment of advanced bladder cancer: Clinical results and immunological effects. Cancer Res 1992; 52: 726–733
   PubMed Web of Science ®Google Scholar
• Hermann G G, Petersen K R, Steven K, Zeuthen J. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: Decreased LAK cytotoxicity caused by low incidence of CD56+ and CD57+ mononuclear blood cells. J Clin Immunol 1990; 10: 311–320
   PubMed Web of Science ®Google Scholar
• Herr H W, Laudone V P, Whitmore W F. An overview of intravesical therapy for superficial bladder tumors. J Urol 1987; 138: 1363–1368
   PubMed Web of Science ®Google Scholar
• Hickish T, Cunningham D, Colston K, et al. The effect of 1,25-dihydroxyvitamin D3 on lymfoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993; 68: 668–672
   PubMed Web of Science ®Google Scholar
• Huland E, Huland H. Local continuous high dose interleukin 2: New therapeutic model for the treatment of advanced bladder carcinoma. Cancer Res 1989; 49: 5469–5474
   PubMed Web of Science ®Google Scholar
• Ikemoto S, Kishimoto T, Wada S, Nishio S, Maekawa M. Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma: Blastogenetic response, interleukin-2 production and interferon-gamma production of lymphocytes. Br J Urol 1990; 65: 333–338
   PubMedGoogle Scholar
• Kragball K. Chair's summary: Vitamin D actions and applications. Dermatol 1993; 992: 1042–1044
   Google Scholar
• McFadden R, Buconjic T, Caceney A, Fraher L. Immunopathogenesis of sarcoidosis: Vitamin D sterols downregulate the cellular immune response. Am Rev Respir Dis 1992; 145(4, pt2)A231–A231
   Google Scholar
• McFadden R, Buconjic T, Caceney A, Fraher L. Immune regulation in sarcoidosis: Vitamin D analogues modify lymphocyte responsiveness. Eur Resp J 1992; 5(Suppl 15)398S
   Google Scholar
• Merguerian P A, Donahue L, Crockett A TK. Intraluminal interleukin 2 and bacillus calmette-guerin for treatment of bladder cancer: A preliminary report. J Urol 1987; 137: 216–219
   PubMed Web of Science ®Google Scholar
• Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230–239
   PubMed Web of Science ®Google Scholar
• Muller K, Haahr P M, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992; 4: 506–512
   PubMed Web of Science ®Google Scholar
• Murdoch D, Clissold S P. Calcipotriol, A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992; 43: 415–429
   PubMed Web of Science ®Google Scholar
• Muller K. Studies on the role of vitamin D3 in immunoregulation. Thesis, 1994; 1–60, Copenhagen, ISBN 87–985125–0–1: Laboratory for medical immunology, Rigshospitalet
   Google Scholar
• O'Toole C, Perlmann P, Unsgaard B, Moberger G M, Edsmyr F. Cellular immunity to human urinary bladder carcinoma I. Correlation to clinical stage and radiotherapy. Int J Cancer 1972; 10: 77–91
   PubMed Web of Science ®Google Scholar
• Pizza G, Severini G, Mennitti D, De Vinci C, Corrado F. Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Int J Cancer 1991; 34: 359–367
   Google Scholar
• Ravid A, Koren R, Maron L, Liberman U A. 1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells. Mol Cell Endocrinol 1993; 96: 133–139
   PubMed Web of Science ®Google Scholar
• Rebel V I, Ossenkoppele G J, van de Loosdrecht A A, Wijermans W, Beelen R HJ, Lamgenhuijsen M MAC. Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogue. Leukemia Res 1992; 16: 443–451
   PubMed Web of Science ®Google Scholar
• Saunders D E, Christensen C, Wappler N L, et al. Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anticancer Drug 1993; 4: 201–208
   Google Scholar
• Scott-Mackie P, Hickish T, Mortimer P, Sloane J, Cunningham D. Calcipotriol and regression in T-cell lymphoma of skin. Lancet 1993; 342: 172–172
   PubMed Web of Science ®Google Scholar
• Shabahang M, Buras R R, Davoodi F, et al. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 1994; 54: 4057–4064
   PubMed Web of Science ®Google Scholar
• Skowronski R J, Peehl D M, Feldman D. Vitamin D and prostate cancer: 1,25-dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinol 1993; 132: 1952–1960
   PubMed Web of Science ®Google Scholar
• Sone T, McDonnell D P, O'Malley B W, Pike J W. Expression of human vitamin D receptor in Sacchar-omyces cerevisiae, Purification, properties and generation of polyclonal antibodies. J Biol Chem 1990; 265: 21997–22003
   PubMed Web of Science ®Google Scholar
• Song L, Cheng T. Effects of 1,25-dihydroxyvitamin D3 analogue l,24(OH)2–22-ene-24-cyclopropyl D3 on proliferation and differentiation of a human megakaryo-blastic leukemia cell line. Biochem Pharmacol 1992; 43: 2292–2295
   PubMed Web of Science ®Google Scholar
• Thomas M G, Tebbutt S, Williamson R CN. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 1992; 33: 1660–1663
   PubMed Web of Science ®Google Scholar